Global Medical REIT is a reit - healthcare facilities business based in the US. Global Medical REIT shares (GMRE) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $8.64 – a decrease of 0.35% over the previous week. Global Medical REIT employs 26 staff and has a trailing 12-month revenue of around $136.6 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $8.64 |
|---|---|
| 52-week range | $7.64 - $10.71 |
| 50-day moving average | $9.44 |
| 200-day moving average | $9.12 |
| Wall St. target price | $10.91 |
| PE ratio | N/A |
| Dividend yield | $0.84 (9.45%) |
| Earnings per share (TTM) | $-0.02 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $8.67 from 2024-11-19
| 1 week (2024-11-14) | 8.67 |
|---|---|
| 1 month (2024-10-21) | -7.17% |
| 3 months (2024-08-21) | -6.67% |
| 6 months (2024-05-21) | -2.36% |
| 1 year (2023-11-21) | -10.99% |
|---|---|
| 2 years (2022-11-21) | 10.95% |
| 3 years (2021-11-19) | 12.9067 |
| 5 years (2019-11-21) | 9.188 |
Valuing Global Medical REIT stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Global Medical REIT's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Global Medical REIT's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $86.8 million.
The EBITDA is a measure of a Global Medical REIT's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $136.6 million |
|---|---|
| Operating margin TTM | 25.7% |
| Gross profit TTM | $136.9 million |
| Return on assets TTM | 1.71% |
| Return on equity TTM | 0.72% |
| Profit margin | 3.24% |
| Book value | $7.00 |
| Market Capitalization | $598.7 million |
TTM: trailing 12 months
Dividend payout ratio: 365.22% of net profits
Recently Global Medical REIT has paid out, on average, around 400% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Global Medical REIT shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Global Medical REIT's case, that would currently equate to about $0.84 per share.
Global Medical REIT's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Global Medical REIT's most recent dividend payout was on 7 October 2024. The latest dividend was paid out to all shareholders who bought their shares by 19 September 2024 (the "ex-dividend date").
Global Medical REIT's shares were split on a 1:400 basis on 16 November 2014 . So if you had owned 400 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Global Medical REIT shares – just the quantity. However, indirectly, the new 39900% higher share price could have impacted the market appetite for Global Medical REIT shares which in turn could have impacted Global Medical REIT's share price.
Over the last 12 months, Global Medical REIT's shares have ranged in value from as little as $7.6376 up to $10.7101. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Global Medical REIT's is 1.281. This would suggest that Global Medical REIT's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Global Medical REIT Inc. (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems. .
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.